@article{Madhukar Shende_Satish Bodele_Shweta Ghode_Atul Baravkar_Nilesh Nalawade_2021, title={Transferosomes: A promising vesicular-based skin-oriented drug delivery system: https://doi.org/10.54037/WJPS.2021.91009}, volume={9}, url={https://wjpsonline.com/index.php/wjps/article/view/transferosomes-vesicular-based-skin-oriented-dds}, abstractNote={<p>Using vesicular carriers to reduce the obstructive effects of the stratum corneum has recently become a feasible option. The use of transferosomes, also known as ultradeformable lipids or elastic liposomes, for cutaneous administration has generated a lot of interest. They are mainly used to treat a range of chronic skin diseases, but they may also be used to guarantee patient compliance by allowing for concentrated and controlled distribution. The pore size of the stratum corneum may be adjusted by these self-assembled nanocarriers. In transferosomes, you may find edge activators (particular surfactants), phospholipids, buffering agents, and other things. Constructed vesicles have the required flexibility due to the effect of edge activators and their concentration. Elastic liposomes may improve drug solubility, drug loading efficiency, and therapeutic molecule permeability. Transferosomes have a high reflectivity as nanocarriers and offer a flexible basis for transdermal applications. These one-of-a-kind nanocarriers are also very supple and penetrate deeply. These systems are considered to be safe, with efficient delivery methods for chemical moieties that are pharmaceutically or aesthetically active. Recent research has revealed that ultradeformable liposomes are necessary for constant and efficient medication penetration.</p>}, number={10}, journal={World Journal of Pharmaceutical Sciences}, author={Madhukar Shende and Satish Bodele and Shweta Ghode and Atul Baravkar and Nilesh Nalawade}, year={2021}, month={Oct.}, pages={46–55} }